Evidence map›Paper›PMID 34837888›Full record

ArticleAging2021

Inhibition of Fam114A1 protects melanocytes from apoptosis through higher RACK1 expression.

Miaoni Zhou, Fuquan Lin, Xingang Wu, Zhuyi Ping, Wen Xu, Rong Jin, Aie Xu

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Miaoni ZhouThe Third People's Hospital of Hangzhou, Zhejiang, China.
Fuquan LinThe Third People's Hospital of Hangzhou, Zhejiang, China.
Xingang WuThe Third People's Hospital of Hangzhou, Zhejiang, China.
Zhuyi PingThe Third People's Hospital of Hangzhou, Zhejiang, China.
Wen XuThe Third People's Hospital of Hangzhou, Zhejiang, China.
Rong JinThe Third People's Hospital of Hangzhou, Zhejiang, China.
Aie XuThe Third People's Hospital of Hangzhou, Zhejiang, China.
Third People's Hospital of Hangzhou · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fam114A1 is a gene closely related to the development of nerve cells, melanocytes, and nerve cells that originate from the neural crest of the embryonic ectoderm. Recent studies showed that Fam114A1 has a role in the occurrence of ankylosing myelitis spondylitis and autoimmune enteritis; still, its cellular function remains poorly understood. In this study, we investigated the effect of Fam114A1 on the biological activity of melanocytes. We found that the expression of Fam114A1 in vitiligo melanocytes (MCV-L, MCV-N, PI3V) was higher than that in normal melanocytes, and the biological function of melanocytes was significantly affected when the Fam114A1 gene was silenced. Inhibition of Fam114A1 increased proliferation, migration, and melanin synthesis proteins, decreased apoptosis, while its overexpression reversed this process. Mechanistically, we discovered that RACK1 is a target protein of Fam114A1 and that RACK1 can be negatively regulated by Fam114A1. Further study showed that Fam114A1 inhibition could not protect melanocytes from apoptosis once the expression of RACK1 protein was silenced. In summary, Fam114A1 is an effective regulatory protein for regulating the function of melanocytes. Inhibition Fam114A1 protects melanocytes from apoptosis through increasing RACK1.

Indexed as

Neoplasm ProteinsNerve Tissue ProteinsReceptors for Activated C KinaseApoptosisCells, CulturedHumansMelanocytesNeoplasm ProteinsNerve Tissue ProteinsRACK1 protein, humanReceptors for Activated C Kinasefam114a1melanocytesRACK1

Identifiers

PMID34837888
PMCPMC8660612
OpenAlexW3215139610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.